b -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease
暂无分享,去创建一个
Simon A. Moss | Paul Maruff | Colin L. Masters | Greg Savage | William E. Klunk | Chester A. Mathis | Victor L. Villemagne | Christopher C. Rowe | Kerryn E. Pike | C. Rowe | S. Moss | W. Klunk | C. Masters | C. Mathis | P. Maruff | K. Pike | G. Savage | V. Villemagne | S. Ng | Steven Ng
[1] L. Squire,et al. Structure and function of declarative and nondeclarative memory systems. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Mesulam,et al. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. , 2003, Archives of neurology.
[3] Gina N. LaRossa,et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.
[4] . Global prevalence of dementia: a Delphi consensus study , 2006 .
[5] Brian J Cummings,et al. β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease , 1996, Neurobiology of Aging.
[6] P. Scheltens,et al. Advances in the early detection of Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[7] J. Morrison,et al. Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease , 2002, Neuroscience.
[8] J. Sinacore. Multiple regression: Testing and interpreting interactions , 1993 .
[9] D. Balota,et al. Relating anatomy to function in Alzheimer's disease , 1998, Neurology.
[10] Correlation of Entorhinal Amyloid with Memory in Alzheimer’s and Vascular but Not Lewy Body Dementia , 2005, Dementia and Geriatric Cognitive Disorders.
[11] G. E. Alexander,et al. Activation of brain regions vulnerable to Alzheimer's disease: The effect of mild cognitive impairment , 2006, Neurobiology of Aging.
[12] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[13] C. Jack,et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.
[14] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[15] Jean-François Dartigues,et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. , 2005, Brain : a journal of neurology.
[16] L. Danober,et al. Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice , 2003, Neuroscience.
[17] K. Davis,et al. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease , 2006, Neurology.
[18] D. Blacker,et al. The genetics of Alzheimer disease: current status and future prospects. , 1998, Archives of neurology.
[19] W. Klein. Synaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer’s disease , 2006, Alzheimer's & Dementia.
[20] S. Riedel-Heller,et al. Mild cognitive impairment , 2006, Neurology.
[21] S. Filipek,et al. Genetic aspects of Alzheimer's disease. , 2004, Acta neurobiologiae experimentalis.
[22] J. Schneider,et al. Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.
[23] S. Riedel-Heller,et al. Progression of mild cognitive impairment to dementia: a challenge to current thinking. , 2006, The British journal of psychiatry : the journal of mental science.
[24] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[25] Benjamin J. Shannon,et al. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.
[26] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[27] Arthur L. Benton,et al. Differential behavioral effects in frontal lobe disease , 1968 .
[28] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[29] J. Morrison,et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease , 2003, Neurology.
[30] D. Bennett,et al. Mild cognitive impairment in different functional domains and incident Alzheimer’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[31] E. Tangalos,et al. Neuropathologic features of amnestic mild cognitive impairment. , 2006, Archives of neurology.
[32] Paul Edison,et al. Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study , 2006, Annals of neurology.
[33] M. Viitanen,et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease , 2006, Neurology.
[34] D. A. Kenny,et al. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. , 1986, Journal of personality and social psychology.
[35] C. Rowe,et al. Imaging β-amyloid burden in aging and dementia , 2007, Neurology.
[36] H. Engler,et al. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease. , 2006, Brain : a journal of neurology.
[37] H. Engler,et al. PET imaging of amyloid deposition in patients with mild cognitive impairment , 2008, Neurobiology of Aging.
[38] J. Schneider,et al. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. , 2004, Archives of neurology.
[39] P. Maruff,et al. Mild memory impairment in healthy older adults is distinct from normal aging , 2006, Brain and Cognition.
[40] William E. Klunk,et al. The Binding of 2-(4′-Methylaminophenyl)Benzothiazole to Postmortem Brain Homogenates Is Dominated by the Amyloid Component , 2003, The Journal of Neuroscience.
[41] Colin L Masters,et al. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. , 2006, Brain : a journal of neurology.
[42] Yvette I. Sheline,et al. Potential antecedent marker of Alzheimer disease , 2006 .
[43] Charles D. Smith,et al. Neuropathologic substrate of mild cognitive impairment. , 2006, Archives of neurology.
[44] P. Agostinho,et al. Susceptibility of hippocampal neurons to Aβ peptide toxicity is associated with perturbation of Ca2+ homeostasis , 2007, Brain Research.
[45] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] G Ratcliff,et al. Normative Data on the Boston Naming Test and Two Equivalent 30-Item Short Forms , 2000, The Clinical neuropsychologist.
[47] J. Morris,et al. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.
[48] Nick C Fox,et al. Amyloid, hypometabolism, and cognition in Alzheimer disease , 2007, Neurology.
[49] S. M. Sumi,et al. The Mean Aβ Load in the Hippocampus Correlates with Duration and Severity of Dementia in Subgroups of Alzheimer Disease , 1997, Journal of Neuropathology and Experimental Neurology.
[50] A. Smith,et al. Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. , 1996, Dementia.